North Dakota State University NorthShore, Sema4 Partnership Aims to Demonstrate Utility of Genomics for Personalized Care Premium NorthShore University HealthSystem is looking to normalize the use of genomics in patient care, particularly among medically underserved populations. North Dakota Funds Life Sciences Center North Dakota State University said today that it will use $1.4 million in funding from a state program and additional support from Sanford Research and the RJ Lee Group. Lynntech Developing Inexpensive Sample Prep, Testing Platforms for Point-of-Care MDx Premium By Ben Butkus USDA Awards $11M for Plant Genomics North Dakota State, UC-Davis, Michigan State, and U of Minnesota won applied genomics stimulus grants. Funding Update for Mar 24, 2009 Premium Sequencing-Related NSF Grants Awarded Feb. 25 – March 24, 2009 Breaking News Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.